[HTML][HTML] Paired primary and metastatic lesions of patients with ipilimumab-treated melanoma: high variation in lymphocyte infiltration and HLA-ABC expression …
MAJ Gorris, LL van der Woude, LI Kroeze… - … for Immunotherapy of …, 2022 - ncbi.nlm.nih.gov
Background Immune checkpoint inhibitors (ICI) can lead to long-term responses in patients
with metastatic melanoma. Still many patients with melanoma are intrinsically resistant or …
with metastatic melanoma. Still many patients with melanoma are intrinsically resistant or …
Paired primary and metastatic lesions of patients with ipilimumab-treated melanoma: high variation in lymphocyte infiltration and HLA-ABC expression whereas tumor …
MAJ Gorris, LL van der Woude, LI Kroeze… - … for Immunotherapy of …, 2022 - europepmc.org
Background Immune checkpoint inhibitors (ICI) can lead to long-term responses in patients
with metastatic melanoma. Still many patients with melanoma are intrinsically resistant or …
with metastatic melanoma. Still many patients with melanoma are intrinsically resistant or …
[HTML][HTML] Paired primary and metastatic lesions of patients with ipilimumab-treated melanoma: high variation in lymphocyte infiltration and HLA-ABC expression …
MAJ Gorris, LL van der Woude, LI Kroeze… - … for ImmunoTherapy of …, 2022 - jitc.bmj.com
Background Immune checkpoint inhibitors (ICI) can lead to long-term responses in patients
with metastatic melanoma. Still many patients with melanoma are intrinsically resistant or …
with metastatic melanoma. Still many patients with melanoma are intrinsically resistant or …
Paired primary and metastatic lesions of patients with ipilimumab-treated melanoma: high variation in lymphocyte infiltration and HLA-ABC expression whereas tumor …
MAJ Gorris, LL van der Woude… - Journal for …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Immune checkpoint inhibitors (ICI) can lead to long-term responses in patients
with metastatic melanoma. Still many patients with melanoma are intrinsically resistant or …
with metastatic melanoma. Still many patients with melanoma are intrinsically resistant or …
[PDF][PDF] Paired primary and metastatic lesions of patients with ipilimumab-treated melanoma: high variation in lymphocyte infiltration and HLA-ABC expression whereas …
MAJ Gorris, LL van der Woude, L Kroeze, KF Bol… - 2022 - repository.ubn.ru.nl
Background Immune checkpoint inhibitors (ICI) can lead to long-term responses in patients
with metastatic melanoma. Still many patients with melanoma are intrinsically resistant or …
with metastatic melanoma. Still many patients with melanoma are intrinsically resistant or …